Codexis, Inc.

US$1.08As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CDXSHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (14.27%)
Div yield —
ROE (69.36%)
Biotechnology
Beta (5Y) 2.39
PE TTM —
TSR TTM (54.43%)
Mkt cap US$118.3M
ROIC (13.17%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.26
16.57%
(49.66%)
Hold 8|2|10|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
7.52%
9.29%
(0.57%)
4.47%
Revenue$M
10.31
10.62
11.06
10.74
0.65%
4.41%
7.30%
6.19%
Peers (US$118.3M)
Cap (US$)
PE
118.3M
—
117.9M
19.70x
Capital
TTM
5Y
10Y
Leveragex
0.384
(0.022)
(0.014)
EBIT/Intx
1.199
1.000
0.926
Own earn%
3.93
(118.88)
(111.55)
Sh yield%
31.48
13.71
11.19
Owners
Insiders/Inst%
2.99
38.58
Short interest%
1.02
SBC / revenue%
2.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
12–18
$1 testx
0.0
Incr. ROIC%
8